ATEA PHARMACEUTICALS INC (AVIR)

US04683R1068 - Common Stock

3.83  -0.02 (-0.52%)

After market: 3.83 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.00351.40M48.60M0.00
Operating Expenses
120.01M111.20M119.50M36.70M14.60M
Research and Development
70.09M62.40M73.70M15.00M10.20M
Selling, General, and Administrative Expenses
49.92M48.70M45.80M21.60M4.40M
Operating Income
-120.01M-111.20M231.90M12.00M-14.60M
Interest Income/Expense
29.22M11.20M200.00K100.00K600.00K
Non Recurring Items
-44.15M-19.50M-93.50M-23.00MN/A
Income Before Taxes
-134.94M-119.50M138.60M-10.90M-14.00M
Income Tax
1.02M-3.60M17.40MN/AN/A
Net Income
-135.96M-115.90M121.20M-10.90M-14.00M
EBITDA
-119.59M-110.90MN/AN/AN/A
 
Per Share Data
EPS Diluted Total Ops
-1.63-1.391.37-0.13-0.17
Non GAAP EPS
-1.64-1.401.36N/AN/A
 
Statistics
Profit Margin
N/AN/A34.49%-22.43%N/A
Operating Profit Margin
N/AN/A65.99%24.69%N/A

All data in USD

Charts